4.6 Review

The Diagnostic and Prognostic Value of Echocardiographic Strain

Journal

JAMA CARDIOLOGY
Volume 4, Issue 6, Pages 580-588

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamacardio.2019.1152

Keywords

-

Funding

  1. Irene D. Pritzker Foundation

Ask authors/readers for more resources

IMPORTANCE Myocardial deformation or strain by speckle-tracking echocardiography (STE) has become an established echocardiographic modality for the diagnostic and prognostic evaluation of cardiac dysfunction. Current literature supports the incremental value of strain in diagnosis, risk stratification, and prognostication of a multitude of cardiac disease states. OBSERVATIONS Strain has been studied across the clinical spectrum from common to obscure pathologic conditions. This review presents the current literature evaluating characteristic strain patterns across this clinical spectrum, discusses prognostic implications, and provides a case series of classic strain polar maps, which are also known as bull's-eye plots. CONCLUSIONS AND RELEVANCE Characteristic bull's-eye patterns can be used to guide patient evaluation and management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Meeting Abstract Oncology

Risk factors for the development of atrial fibrillation on ibrutinib treatment.

Robert William Lentz, Shuo Ma, Nausheen Akhter

JOURNAL OF CLINICAL ONCOLOGY (2018)

Meeting Abstract Oncology

Incidence of nonvalvular atrial fibrillation on ibrutinib compared to other tyrosine kinase inhibitors: A large multi-institution general practice study.

Joyce Njoroge, Robert William Lentz, Jered Linares, Christopher Gans, Nausheen Akhter

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Chemistry, Multidisciplinary

Nanorod Dissolution Quenched in the Aggregated State

Gayan Rubasinghege, Robert W. Lentz, Heaweon Park, Michelle M. Scherer, Vicki H. Grassian

LANGMUIR (2010)

Article Multidisciplinary Sciences

Simulated atmospheric processing of iron oxyhydroxide minerals at low pH: Roles of particle size and acid anion in iron dissolution

Gayan Rubasinghege, Robert W. Lentz, Michelle M. Scherer, Vicki H. Grassian

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Oncology

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Robert Lentz, Al B. Benson, Sheetal Kircher

JOURNAL OF SURGICAL ONCOLOGY (2019)

Article Oncology

Risk factors for the development of atrial fibrillation on ibrutinib treatment

Robert Lentz, Joseph Feinglass, Shuo Ma, Nausheen Akhter

LEUKEMIA & LYMPHOMA (2019)

Meeting Abstract Oncology

A prospective study tracking longitudinal changes in genome-wide cell-free DNA (cfDNA) methylation to identify early nonresponders to cancer treatment.

Andrew A. Davis, Wade Thomas Iams, David Chan, Michael S. Oh, Robert William Lentz, Rohith Srivas, Nicole Lambert, Alex Robertson, Neil Peterman, Abhik Shah, Timothy Wilson, Jason Close, Peter George, Haleigh Wood, Ayse Tezcan, Ram Yalamanchili, Ken Nesmith, John C. Spinosa, Haluk Tezcan, Young Kwang Chae

JOURNAL OF CLINICAL ONCOLOGY (2019)

Meeting Abstract Oncology

Whole-genome cell-free DNA (cfDNA) changes as a dynamic blood-based biomarker for early response assessment of advanced tumors.

Andrew A. Davis, Wade Thomas Iams, David Chan, Michael S. Oh, Robert William Lentz, Neil Peterman, Alex Robertson, Abhik Shah, Rohith Srivas, Nicole Lambert, Timothy Wilson, Peter George, Becky Wong, Ayse Tezcan, Ram Yalamanchili, Ken Nesmith, John C. Spinosa, Haluk Tezcan, Young Kwang Chae

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Oncology

Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors

Andrew A. Davis, Wade T. Iams, David Chan, Michael S. Oh, Robert W. Lentz, Neil Peterman, Alex Robertson, Abhik Shah, Rohith Srivas, Timothy J. Wilson, Nicole J. Lambert, Peter S. George, Becky Wong, Haleigh W. Wood, Jason C. Close, Ayse Tezcan, Ken Nesmith, Haluk Tezcan, Young Kwang Chae

MOLECULAR CANCER THERAPEUTICS (2020)

Review Oncology

Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?

Robert W. Lentz, Meryl D. Colton, Siddhartha S. Mitra, Wells A. Messersmith

Summary: While immunotherapy has revolutionized the treatment of many types of advanced cancer, most patients still do not derive benefit. Innate immune checkpoint inhibitors are a promising new target that can disrupt inhibitory interactions between tumor and both phagocytes and natural killer cells. This area of drug development targeting phagocytosis and natural killer-cell checkpoints could revolutionize immune-based cancer therapies.

MOLECULAR CANCER THERAPEUTICS (2021)

Editorial Material Oncology

Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases

Robert W. Lentz, Wells A. Messersmith

JOURNAL OF CLINICAL ONCOLOGY (2021)

Meeting Abstract Oncology

Serial changes in tumor-derived whole-genome cfDNA fraction to identify early disease progression prior to imaging

Andrew A. Davis, Wade T. Iams, David Chan, Michael S. Oh, Robert W. Lentz, Neil Peterman, Alex Robertson, Abhik Shah, Rohith Srivas, Nicole Lambert, Tim Wilson, Peter George, Becky Wong, Ayse Tezcan, Ram Yalamanchili, Ken Nesmith, John C. Spinosa, Haluk Tezcan, Young Kwang Chae

CANCER RESEARCH (2019)

No Data Available